ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.482,50
0,00%
S&P 500
6.114,63
-0,01%
Dow Jones
44.546,08
-0,37%
Euro vs US Dollar
1,04869
-0,08%
Bitcoin
96.076,81
-0,05%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Athira Pharma Inc (ATHA) Börsenkurse

Athira Pharma Inc

Athira Pharma Inc (ATHA)

Athena Gold Corporation
0,468
0,0281
(6,39%)
Geschlossen 17 Februar 10:00PM
Verzögert um 15 Minuten
0,4773
0,0093
(1,99%)
Nach Börsenschluss: 1:00AM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,4773
Gebot
0,446
Fragen
0,4774
Volumen
126.298
0,435 Tagesbereich 0,4779
0,4115 52-Wochen-Bereich 4,2984
Marktkapitalisierung
18,457M
Handelsende
0,4399
Handelsbeginn
0,4599
Letzte Trade
25
@
0.4773
Letzter Handelszeitpunkt
Finanzvolumen
US$ 57.091
VWAP
0,452035
Durchschnittliches Volumen (3 Mio.)
261.594
Ausgegebene Aktien
38.669.073
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,15
Gewinn pro Aktie (EPS)
-3,04
Erlöse
1,63M
Nettogewinn
-117,67M

Über Athira Pharma Inc

Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease. Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.athira.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Athira Pharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ATHA. The last closing price for Athira Pharma was US$0,44. Over the last year, Athira Pharma shares have traded in a share price range of US$ 0,4115 to US$ 4,2984.

Athira Pharma currently has 38.669.073 shares in issue. The market capitalisation of Athira Pharma is US$17,01 million. Athira Pharma has a price to earnings ratio (PE ratio) of -0.15.

ATHA Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 Januar 2025
ATHA (6,39%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 Januar 2025
ATHA (6,39%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 Januar 2025
ATHA (6,39%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 Januar 2025
ATHA (6,39%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 Januar 2025
ATHA (6,39%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 Januar 2025
ATHA (6,39%)

Form 8-K - Current report
Edgar (US Regulatory)
07 November 2024
ATHA (6,39%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
29 Oktober 2024
ATHA (6,39%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0479-9.120335110430.52520.52520.42291997960.4543932CS
4-0.0478-9.103027994670.52510.570.42292234240.50683899CS
12-0.1818-27.58306781980.65910.67890.42292615940.56488541CS
26-2.5227-84.0933.670.411527534260.63688472CS
52-2.7427-85.17701863353.224.29840.411514942670.81494707CS
156-9.5627-95.246015936310.0414.220.41157336351.82793455CS
260-19.4727-97.60751879719.9534.790.41156615105.07721797CS

ATHA - Frequently Asked Questions (FAQ)

What is the current Athira Pharma share price?
The current share price of Athira Pharma is US$ 0,4773
How many Athira Pharma shares are in issue?
Athira Pharma has 38.669.073 shares in issue
What is the market cap of Athira Pharma?
The market capitalisation of Athira Pharma is USD 17,01M
What is the 1 year trading range for Athira Pharma share price?
Athira Pharma has traded in the range of US$ 0,4115 to US$ 4,2984 during the past year
What is the PE ratio of Athira Pharma?
The price to earnings ratio of Athira Pharma is -0,15
What is the cash to sales ratio of Athira Pharma?
The cash to sales ratio of Athira Pharma is 10,93
What is the reporting currency for Athira Pharma?
Athira Pharma reports financial results in USD
What is the latest annual turnover for Athira Pharma?
The latest annual turnover of Athira Pharma is USD 1,63M
What is the latest annual profit for Athira Pharma?
The latest annual profit of Athira Pharma is USD -117,67M
What is the registered address of Athira Pharma?
The registered address for Athira Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Athira Pharma website address?
The website address for Athira Pharma is www.athira.com
Which industry sector does Athira Pharma operate in?
Athira Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
JTAIJet AI Inc
US$ 6,02
(133,33%)
104,48M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
WRDWeRide Inc
US$ 31,4877
(83,39%)
21,07M
INLFINLIF Limited
US$ 16,27
(80,58%)
7,68M
MBRXMoleculin Biotech Inc
US$ 2,1201
(66,94%)
136,66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3,08
(-56,31%)
430,77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3,36
(-52,68%)
5,21k
CSAICloudastructure Inc
US$ 19,0001
(-49,58%)
1,03M
NEXNNexxen International Ltd
US$ 10,30
(-49,16%)
164,82k
BSLKBolt Projects Holdings Inc
US$ 0,6626
(-46,13%)
13,4M
CNSPCNS Pharmaceuticals Inc
US$ 0,1415
(31,26%)
489,28M
MGOLMGO Global Inc
US$ 0,7176
(-15,08%)
417,31M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
INTCIntel Corporation
US$ 23,60
(-2,20%)
230,26M
NVDANVIDIA Corporation
US$ 138,85
(2,63%)
194,99M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ATHA
Athira Pharma
AMEX
CHIQ
Global X MSCI China Cons...
LSE
PUAL
Puma Alpha Vct
BOV
AVGO34M
Broadcom
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten